Chenguang Biotech Group Net Asset Quality Index
Chenguang Biotech Group net asset quality index. Chenguang Biotech Group (300138) has a Net Asset Quality Index of 35.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.62 Billion minus total liabilities of CN¥6.16 Billion yields net assets of CN¥3.46 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Chenguang Biotech Group's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Chenguang Biotech Group (2007–2025)
Net asset quality index of Chenguang Biotech Group from 2007 to 2025. This chart shows how Chenguang Biotech Group's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 35.9%, representing net assets of CN¥3.46 Billion against total assets of CN¥9.62 Billion CNY. Check asset allocation strategy of Chenguang Biotech Group to assess the company's strategic physical and investment asset allocation.
Chenguang Biotech Group Net Asset Quality Index by Year (2007–2025)
Chenguang Biotech Group net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Chenguang Biotech Group from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Chenguang Biotech Group market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 36.2% | CN¥3.44 Billion | CN¥9.50 Billion | CN¥6.07 Billion | ▲ +1.2 pp |
| 2024 | 35.0% | CN¥3.15 Billion | CN¥9.02 Billion | CN¥5.87 Billion | ▼ -6.4 pp |
| 2023 | 41.4% | CN¥3.53 Billion | CN¥8.54 Billion | CN¥5.01 Billion | ▼ -5.1 pp |
| 2022 | 46.4% | CN¥3.21 Billion | CN¥6.92 Billion | CN¥3.71 Billion | ▼ -0.3 pp |
| 2021 | 46.7% | CN¥2.78 Billion | CN¥5.96 Billion | CN¥3.17 Billion | ▲ +2.5 pp |
| 2020 | 44.2% | CN¥2.06 Billion | CN¥4.65 Billion | CN¥2.59 Billion | ▲ +5.6 pp |
| 2019 | 38.6% | CN¥1.74 Billion | CN¥4.51 Billion | CN¥2.77 Billion | ▼ -13.2 pp |
| 2018 | 51.8% | CN¥1.74 Billion | CN¥3.36 Billion | CN¥1.62 Billion | ▼ -4.7 pp |
| 2017 | 56.5% | CN¥1.62 Billion | CN¥2.87 Billion | CN¥1.25 Billion | ▼ -4.7 pp |
| 2016 | 61.2% | CN¥1.52 Billion | CN¥2.49 Billion | CN¥967.46 Million | ▼ -10.5 pp |
| 2015 | 71.7% | CN¥1.43 Billion | CN¥1.99 Billion | CN¥564.12 Million | ▲ +4.8 pp |
| 2014 | 66.9% | CN¥1.01 Billion | CN¥1.51 Billion | CN¥499.69 Million | ▲ +6.2 pp |
| 2013 | 60.7% | CN¥990.39 Million | CN¥1.63 Billion | CN¥641.26 Million | ▼ -8.3 pp |
| 2012 | 69.0% | CN¥997.86 Million | CN¥1.45 Billion | CN¥447.73 Million | ▼ -17.8 pp |
| 2011 | 86.8% | CN¥968.71 Million | CN¥1.12 Billion | CN¥147.16 Million | ▲ +5.6 pp |
| 2010 | 81.2% | CN¥933.05 Million | CN¥1.15 Billion | CN¥215.92 Million | ▲ +28.9 pp |
| 2009 | 52.3% | CN¥210.67 Million | CN¥402.85 Million | CN¥192.17 Million | ▲ +13.9 pp |
| 2008 | 38.4% | CN¥147.93 Million | CN¥385.24 Million | CN¥237.31 Million | ▼ -15.9 pp |
| 2007 | 54.3% | CN¥101.70 Million | CN¥187.20 Million | CN¥85.49 Million | — |